FDA Unlikely To Act Unilaterally To Increase ClinicalTrials.gov Postings
Executive Summary
FDA believes it has the authority to independently post clinical study information on ClinicalTrials.gov, but does not plan to create a systematic process for increasing the number of industry-sponsored trials listed on the site